Mutations in PIK3CA are associated with increased activation of the Akt pathway, tumor growth, and invasiveness (133, 134), with the overexpression of PIK3CA being associated with poorer patient outcomes (Figure 3A) (135). This evidence concerns the gene PIK3CA and neoplasm.